Follow
Alison McDonnell
Alison McDonnell
Verified email at telethonkids.org.au
Title
Cited by
Cited by
Year
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2
C Jackaman, CS Bundell, BF Kinnear, AM Smith, P Filion, D van Hagen, ...
The Journal of Immunology 171 (10), 5051-5063, 2003
2422003
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
AK Nowak, AM Cook, AM McDonnell, MJ Millward, J Creaney, RJ Francis, ...
Annals of Oncology 26 (12), 2483-2490, 2015
952015
Tumor‐infiltrating dendritic cells exhibit defective cross‐presentation of tumor antigens, but is reversed by chemotherapy
AM McDonnell, WJ Lesterhuis, A Khong, AK Nowak, RA Lake, AJ Currie, ...
European journal of immunology 45 (1), 49-59, 2015
892015
Tumor antigen cross‐presentation and the dendritic cell: where it all begins?
AM McDonnell, BWS Robinson, AJ Currie
Journal of Immunology Research 2010 (1), 539519, 2010
862010
Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation
AJ Currie, A Prosser, A McDonnell, AL Cleaver, BWS Robinson, ...
The Journal of Immunology 183 (12), 7898-7908, 2009
772009
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies
AM Cook, AM McDonnell, RA Lake, AK Nowak
Oncoimmunology 5 (3), e1066062, 2016
732016
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ...
Frontiers in Immunology 11, 584423, 2020
552020
CD8α+ DC are not the sole subset cross‐presenting cell‐associated tumor antigens from a solid tumor
AM McDonnell, AC Prosser, I Van Bruggen, BWS Robinson, AJ Currie
European journal of immunology 40 (6), 1617-1627, 2010
532010
Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
KM Audsley, AM McDonnell, J Waithman
Cells 9 (3), 565, 2020
412020
Contribution of the immune system to the chemotherapeutic response
AM McDonnell, AK Nowak, RA Lake
Seminars in immunopathology 33, 353-367, 2011
412011
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors
TM Meniawy, RA Lake, AM McDonnell, MJ Millward, AK Nowak
Lung Cancer 93, 9-16, 2016
332016
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation
AM McDonnell, AJ Currie, M Brown, K Kania, B Wylie, A Cleaver, R Lake, ...
Oncoimmunology 1, 840-846, 2012
332012
Immune checkpoint inhibition for the treatment of mesothelioma
AK Nowak, A McDonnell, A Cook
Expert Opinion on Biological Therapy 19 (7), 697-706, 2019
232019
Restoration of defective cross-presentation in tumors by gemcitabine
AM McDonnell, W Joost Lesterhuis, A Khong, AK Nowak, RA Lake, ...
Oncoimmunology 4 (5), e1005501, 2015
222015
Fine-tuning the tumour microenvironment: current perspectives on the mechanisms of tumour immunosuppression
JD Armitage, HV Newnes, A McDonnell, A Bosco, J Waithman
Cells 10 (1), 56, 2021
202021
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
SJ Dart, AM Cook, MJ Millward, AM McDonnell, WL Chin, MU Hakeem, ...
Scientific Reports 11 (1), 15312, 2021
172021
Malignant pleural effusions—a window into local anti-tumor T cell immunity?
N Principe, J Kidman, RA Lake, WJ Lesterhuis, AK Nowak, AM McDonnell, ...
Frontiers in Oncology 11, 672747, 2021
162021
IFNβ is a potent adjuvant for cancer vaccination strategies
KM Audsley, T Wagner, C Ta, HV Newnes, AC Buzzai, SA Barnes, ...
Frontiers in Immunology 12, 735133, 2021
122021
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
J Chee, MW Watson, A Chopra, B Nguyen, AM Cook, J Creaney, ...
BMC research notes 11, 1-6, 2018
102018
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell …
AM McDonnell, A Cook, BWS Robinson, RA Lake, AK Nowak
BMC cancer 17, 1-15, 2017
92017
The system can't perform the operation now. Try again later.
Articles 1–20